@CrumblingCookie sadly dopamine agonists are not usually prescribed to patients, even in Parkinsons, as they usually just prescribe Levodopa, so of course none of these drugs are commonly prescribed.
Pramixepole is the new dopamine agonist and that increases noradrenaline, and as far as I know, Amantidine and especially memantine, are commonly prescribed off-label, for many conditions such as MS and depression.
Why isn’t Bupropion a good DA reuptake inhibitor? It’s even combined with naltrexone, in a formula called Mysimba, which creates an anti-opioid, anti endotoxin, pro dopamine and noradrenaline effect